ArticlePloS one2025
The relationship between the structure of firms' human capital and corporate innovation performance.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Innovation in enterprise development is undoubtedly important. The relationship between its structure and the formation of enterprise innovation factors is at the core, so it is crucial to clarify them. Therefore, based on data on A-share listed companies in China from 2007 to 2022, this paper adopts a multilevel structural equation model to explore the effect of the structure of human capital on enterprise innovation performance. Unlike prior studies, this paper divides innovation performance by enterprises into "substantive innovation" and "strategic innovation." Our results show that human capital plays an important role in promoting both strategic and substantive innovation, which is achieved mainly by increasing technological intensity, investing more in R&D, and receiving more government subsidies. In addition, the heterogeneity test shows that this facilitating role is significant in both samples, divided into the criteria of firm ownership and compensation incentives. However, they have different degrees of influence. This provides empirical support for the response by Chinese enterprises regarding the national development strategy and their new ideas about cultivating high-quality technological innovation and achieving sustainable development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.